EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings

Halit Kandemir, Güner Kılıç, Ali Karataş, Beril Demir, Enes Cömert, Derya Kirman, Çağdaş Kalkan, Murat Kekilli, Tarkan Karakan, Mehmet Cindoruk

The European Research Journal · 2026-12-01 · 1408-1415

DOI: 10.18621/eurj.1295 ↗
AbstractBibliografische Angaben

Abstract

Objective: To evaluate the association between repeated guaiac-based fecal occult blood test (gFOBT) positivity and clinically significant colonoscopic and histopathological findings, particularly colorectal malignancy. Methods: This retrospective, single-center cohort study included patients with positive gFOBT results at the Gastroenterology Outpatient Clinic of Gazi University Faculty of Medicine between June 2017 and October 2025. Patients were categorized into 3 groups based on gFOBT results: single positive (Group 1), 2 consecutive positive tests within 1 month (Group 2), and an initial positive followed by a negative test within 1 month (Group 3). Colonoscopic and histopathological findings were compared between groups. Multivariable logistic regression analysis was conducted to identify independent predictors of malignant pathology. Results: Of 1442 patients with positive gFOBT results, 735 (50.9%) underwent diagnostic colonoscopy. Colorectal malignancy was detected in 55 patients (7.5%) undergoing colonoscopy. Malignancy rates differed significantly among groups: 5.1% in Group 1, 17.4% in Group 2, and 0% in Group 3 (P < .001). Repeated gFOBT positivity was independently associated with malignant findings (odds ratio [OR], 3.68; 95% CI, 2.03 to 6.69; P < .001). Normal findings were significantly more frequent in patients with a single positive test, whereas malignant findings were markedly higher in patients with repeated positivity. Conclusions: Repeated gFOBT positivity is strongly associated with clinically significant colonoscopic pathology, particularly colorectal malignancy. Patients with consecutive positive gFOBT results represent a high-risk subgroup and should be prioritized for prompt diagnostic colonoscopy within colorectal cancer screening programs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →